SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-016621
Filing Date
2018-11-28
Accepted
2018-11-28 06:27:01
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k1018_therapixbiosciences.htm 6-K 19603
2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA f6k1018ex99-1_therapixbio.htm EX-99.1 632668
  Complete submission text file 0001213900-18-016621.txt   2476532

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE trpx-20180630.xml EX-101.INS 433528
4 XBRL SCHEMA FILE trpx-20180630.xsd EX-101.SCH 41774
5 XBRL CALCULATION FILE trpx-20180630_cal.xml EX-101.CAL 39279
6 XBRL DEFINITION FILE trpx-20180630_def.xml EX-101.DEF 78792
7 XBRL LABEL FILE trpx-20180630_lab.xml EX-101.LAB 198787
8 XBRL PRESENTATION FILE trpx-20180630_pre.xml EX-101.PRE 137461
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 181204123
SIC: 2834 Pharmaceutical Preparations